PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Ulm
About this trial
PaCaReg is a multicenter registry trial aiming in the assessement of clinical, epidemiological and biological profiles in patients with pancreatic ductal adenocarcinoma
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Treatment naive histologically or cytologically proven pancreatic ductal adenocarcinoma (PDAC) or highly suspicious diagnosis (only pre-curative-intended resection)
Age =>18 years
written informed consent
Disqualifiers
papillary cancer
neuroendocrine pancreatic tumors
Trial population
All adult newly diagnosed patients with a PDAC could be included in the registry trial.
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
General assessment of applied therapy modalities in pancreatic cancer
Time frame
First diagnose to death or end of surveillance (5 years after curative resection)2
Quality of life in pancreatic cancer patients
EORTC QLQ c30 and PAN 26
Time frame
First diagnose to death or end of surveillance (5 years after curative resection)Secondary outcomes
1
General epidemiologic assessment
Epidemiologic questionaire
Time frame
First diagnose to death or end of surveillance (5 years after curative resection)2
Assessment of tumor surveillance in pancreatic cancer patients
Time frame
First diagnose to death or end of surveillance (5 years after curative resection)3
Evaluation of predictive and prognostic markers
Time frame
First diagnose to death or end of surveillance (5 years after curative resection)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov